ClinicalTrials.gg
Drug

Anlotinib clinical trials

Also written AL3818 and ALTN.

Includes 94 studies of Catequentinib hydrochloride.

studies test it
374
open now
142
in phase 3
38
first study started
2011

How each study uses anlotinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the anlotinib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Anlotinib
146
Anlotinib Hydrochloride
8
FOCUS V
4
Anlotinib Hydrochloride Capsules
3
FuKeWei
2

Development codes

AL3818
22

Other names

ALTN
2
Catequentinib
1

In one entry with another drug

Given together, or one or the other

sintilimab combined with anlotinib
3
Anlotinib plus Sintilimab
2
Anlotinib Plus Penpulimab
2
Anlotinib & Penpulimab
2
AK104+anlotinib
2
Toripalimab and Anlotinib
2
benmelstobart combined with chemotherapy and anlotinib
2
Anlotinib and Benmelstobart
2

Studies by the year they started

373 studies that test it; most in 2021 (58); 1 more planned to start later

Studies that test anlotinib, by start year
YearStudies
20111
20137
20141
20157
20164
20172
201832
201953
202043
202158
202236
202328
202436
202526
202639

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
45
Phase 2
291
Phase 3
38
Phase 4
16
No phase
23

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 59 · Other 315

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (49) · Sun Yat-sen University (24) · Fudan University (15) · Tianjin Medical University Cancer Institute and Hospital (14) · The First Affiliated Hospital with Nanjing Medical University (13) · Shanghai Chest Hospital (12) · Zhejiang Cancer Hospital (12) · Henan Cancer Hospital (11)

Often tested with

Tested in the same studies.

Benmelstobart (44) · Penpulimab (25) · Sintilimab (20) · Toripalimab (18) · Tislelizumab (14) · Cadonilimab (10) · Immune checkpoint inhibitors (6) · Paclitaxel (6)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 33, 3 in phase 3

Studies that test anlotinib, phase 3 first.

Studies

Open first, then newest update. How each study uses anlotinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 374

See all 374 studies that test anlotinib →

Given beside what is tested · 43 — anlotinib is usual care or a partner of the new treatment

Showing 20 of 43.

As the comparator · 1 — what is tested is compared with anlotinib